BDBM72301 MLS000392519::N-[2-[(5E)-2,4-diketo-5-p-anisylidene-thiazolidin-3-yl]ethyl]-2,3-dihydro-1,4-benzodioxin-3-carboxamide::N-[2-[(5E)-5-[(4-methoxyphenyl)methylidene]-2,4-bis(oxidanylidene)-1,3-thiazolidin-3-yl]ethyl]-2,3-dihydro-1,4-benzodioxine-3-carboxamide::N-[2-[(5E)-5-[(4-methoxyphenyl)methylidene]-2,4-dioxo-1,3-thiazolidin-3-yl]ethyl]-2,3-dihydro-1,4-benzodioxine-3-carboxamide::N-[2-[(5E)-5-[(4-methoxyphenyl)methylidene]-2,4-dioxo-3-thiazolidinyl]ethyl]-2,3-dihydro-1,4-benzodioxin-3-carboxamide::SMR000261478::cid_15945127
SMILES COc1ccc(\C=C2\SC(=O)N(CCNC(=O)C3COc4ccccc4O3)C2=O)cc1
InChI Key InChIKey=JLXJZVIFHCHJSG-UHFFFAOYSA-N
Data 1 EC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 72301
TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development
US Patent
Glaxosmithkline Intellectual Property Development
US Patent
Affinity DataIC50: 20nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
